A new study found that a combination of hormone therapy and the GLP-1 medication tirzepatide (Zepbound) led to 35% more ...
Tirzepatide, a once-weekly GIP/GLP-1 receptor agonist, is a medicine used for weight reduction in adults with obesity. A new analysis of the SURMOUNT clinical trials reveals that the medicine, ...
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from drugmaker Eli Lilly. In a head-to-head comparison of the two GLP-1 drugs, adults ...
Choosing the right dumbbell weight is not just a matter of preference—it’s a strategic decision that directly impacts your fitness journey. This selection process is deeply personal, shaped by your ...
Rivus Pharmaceuticals’ fat-busting, muscle-sparing drug candidate reduced liver fat in a phase 2 trial while showcasing the drug's obesity potential. The biotech evaluated the candidate, dubbed HU6, ...
Weight loss medications may help adults who are ages 65 years or older improve their health and manage obesity-related conditions. The benefits and risks depend on the drug, your overall health, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results